Scott Shuda Biography and Net Worth

Director of InfuSystem

Scott A. Shuda has been a member of the Company’s Board of Directors since September 7, 2016 and served as Chairman of the Board from December 19, 2018 to May 16, 2025. Mr. Shuda is a Managing Director and Co-founder of Meridian OHC Partners, LP (“Meridian”) and BlueLine Partners, LLC, investment firms that focus on publicly listed technology and healthcare companies. Mr. Shuda has served as a director of Iridex Corporation ("Iridex") (NASDAQ: IRIX), a global leader in ophthalmic laser systems since 2019 and was elected chairman of the board effective June 24, 2020. He also serves as a member of the compensation committee and the nominating & governance committees. He previously served on the Iridex Board from 2012 to 2017. Mr. Shuda holds both a Juris Doctor degree and a Master of Business Administration degree from Georgetown University.

Mr. Shuda has extensive experience with small public companies particularly those within the medical devices industry. He brings more than 25 years of professional experience in law, technology and entrepreneurial endeavors, including transactions that range from initial public offerings and venture financings to mergers and acquisitions. Mr. Shuda also serves as the Managing Director of TSV Investment Partners, LLC, which is the sole general partner of Meridian and a Company stockholder.

What is Scott Shuda's net worth?: The estimated net worth of Scott Shuda is at least $836.60 thousand as of August 22nd, 2025. Mr. Shuda owns 94,000 shares of InfuSystem stock worth more than $836,600 as of July 23rd. This net worth approximation does not reflect any other investments that Mr. Shuda may own. Learn More about Scott Shuda's net worth.
How do I contact Scott Shuda?: The corporate mailing address for Mr. Shuda and other InfuSystem executives is 3851 West Hamlin Road, Rochester Hills, MI 48309, United States. InfuSystem can also be reached via phone at (248) 291-1210. Learn More on Scott Shuda's contact information.
Has Scott Shuda been buying or selling shares of InfuSystem?: Scott Shuda has not been actively trading shares of InfuSystem in the last ninety days. Most recently, Scott Shuda sold 5,752 shares of the business's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $9.67, for a transaction totalling $55,621.84. Following the completion of the sale, the director now directly owns 94,000 shares of the company's stock, valued at $908,980. Learn More on Scott Shuda's trading history.
Who are InfuSystem's active insiders?: InfuSystem's insider roster includes Kenneth Eichenbaum (Director), Paul Gendron (Director), Carrie Lachance (President and Chief Executive Officer), Scott Shuda (Director), and Barry Steele (Executive Vice President and Chief Financial Officer). Learn More on InfuSystem's active insiders.
Are insiders buying or selling shares of InfuSystem?: During the last year, InfuSystem insiders bought shares 5 times. They purchased a total of 17,064 shares worth more than $150,396.24. During the last year, insiders at the sold shares 1 times. They sold a total of 5,752 shares worth more than $55,621.84. The most recent insider tranaction occured on May, 11th when CEO Carrie Lachance bought 1,000 shares worth more than $8,460.00. Insiders at InfuSystem own 10.8% of the company. Learn More about insider trades at InfuSystem.
Information on this page was last updated on 5/11/2026.

Scott Shuda Insider Trading History at InfuSystem

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/22/2025	Sell	5,752	$9.67	$55,621.84	94,000
3/31/2020	Sell	169,960	$8.37	$1,422,565.20
9/5/2019	Buy	3,004	$4.97	$14,929.88
6/14/2019	Buy	4,723	$4.51	$21,300.73
3/20/2019	Buy	11,224	$4.37	$49,048.88
9/14/2018	Buy	21,959	$3.32	$72,903.88	3,504,666
9/12/2018	Buy	40,892	$3.30	$134,943.60	3,504,666
9/10/2018	Buy	15,651	$3.30	$51,648.30
9/7/2018	Buy	23,406	$3.24	$75,835.44
9/5/2018	Buy	9,548	$3.23	$30,840.04
8/30/2018	Buy	72,479	$3.16	$229,033.64

Scott Shuda Buying and Selling Activity at InfuSystem

InfuSystem Company Overview

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Today's Range

Now: $8.91

$8.88

$8.92

50 Day Range

MA: $9.31

$8.61

$10.16

2 Week Range

Now: $8.91

$5.43

$11.04

Volume

5,225 shs

Average Volume

168,649 shs

Market Capitalization

$179.72 million

P/E Ratio

148.44

Dividend Yield

N/A

Beta

1.4